SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17262850
Source:
http://linkedlifedata.com/resource/pubmed/id/17262850
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0289884
,
umls-concept:C0751964
,
umls-concept:C1274040
pubmed:issue
1
pubmed:dateCreated
2007-2-5
pubmed:abstractText
To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7707449
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/copolymer 1
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0364-5134
pubmed:author
pubmed-author:CoylePatricia KPK
,
pubmed-author:FordCoreyC
,
pubmed-author:JohnsonKennethK
,
pubmed-author:KadoshShaulS
,
pubmed-author:LadkaniDavidD
,
pubmed-author:MillerAaronA
,
pubmed-author:NarayanaPonnada APA
,
pubmed-author:O'ConnorPaulP
,
pubmed-author:PROMiSe Trial Study Group
,
pubmed-author:PardoLillianL
,
pubmed-author:WolinskyJerry SJS
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14-24
pubmed:meshHeading
pubmed-meshheading:17262850-Adult
,
pubmed-meshheading:17262850-Disability Evaluation
,
pubmed-meshheading:17262850-Double-Blind Method
,
pubmed-meshheading:17262850-Female
,
pubmed-meshheading:17262850-Follow-Up Studies
,
pubmed-meshheading:17262850-Humans
,
pubmed-meshheading:17262850-Immunosuppressive Agents
,
pubmed-meshheading:17262850-International Cooperation
,
pubmed-meshheading:17262850-Male
,
pubmed-meshheading:17262850-Middle Aged
,
pubmed-meshheading:17262850-Multiple Sclerosis, Chronic Progressive
,
pubmed-meshheading:17262850-Peptides
,
pubmed-meshheading:17262850-Proportional Hazards Models
,
pubmed-meshheading:17262850-Retrospective Studies
,
pubmed-meshheading:17262850-Severity of Illness Index
,
pubmed-meshheading:17262850-Sex Factors
pubmed:year
2007
pubmed:articleTitle
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
pubmed:affiliation
Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA. jerry.s.wolinsky@uth.tmc.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Multicenter Study